Molecular Diagnostics Market (By Product- instruments, reagents, software & services, Market By Technology– polymerase chain reactions (PCR), hybridization, DNA sequencing, microarray, Market By Application- infectious diseases, oncology, genetic testing, blood screening, Market By End User- hospitals, laboratories- Global Industry Size, Share, Trends, and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 150

Introduction

The molecular diagnostic is a method which is used to identify and examine nucleic acids or proteins at a molecular level. This method is used to evaluate the genetic makeup to an individual to identify predisposition to a particular disease to condition and detect it. This method is mainly used to diagnose disease and risk occurred.  It also mainly used to decide the therapies which are suitable for the individual patients.

Market Dynamics

Growing prevalence of infectious diseases & cancers, rising awareness and acceptance of personalized medicines, increase in the biomarker identification, and improvement in molecular diagnostics are some of the major factors driving the growth of the market. Additionally, technological advancement in molecular diagnostics is also responsible to drive the market, as they provide greater accuracy, portability, and cost effectiveness. Moreover, rise in funding by governments and various organizations in the clinical studies in the molecular diagnosis space is expected to propel the growth of the market. Increasing geriatric population is also one of the major factor boosting the growth of the market.

However, stringent regulatory necessities for the approval of recent molecular diagnostics methods are some of the restraining factors hampering the growth of the market. Additionally, the market consists of several opportunities such as rising adoption of the molecular diagnostics in the developing economies.

Market Classification and Overview

The global molecular diagnostics market is segmented into product, technology, application, end-user, and region.

On the basis of product, the market is segmented into instruments, reagents, software & services.

On the basis of technology, the market is segmented into polymerase chain reactions (pcr), hybridization, DNA sequencing, microarray, and others.

Based on the application, the market is segmented into infectious diseases, oncology, genetic testing, blood screening, and others

On the basis of end-user, the market is segmented into hospitals, laboratories, and others.

Regional Overview

Geographically, the global molecular diagnostics market is bifurcated into four regions such as North America, Europe, Asia Pacific (APAC), and Latin America, Middle East & Africa (LAMEA).

North America is expected to be the largest region during the forecast period 2018-2026 owing to the presence of well-established diagnostic infrastructure and technological improvements in the field of molecular diagnostics.

Asia Pacific is expected to drive significantly during the forecasted period owing to the presence of large targeted population and high unmet clinical needs. Moreover, the increasing government initiatives in the countries such as India and China, to develop health infrastructure us likely to propel the growth of the market in this region.

Europe is expected to hold the major share during the forecast period 2018-2026 owing to the rising incidences of lifestyles and infectious diseases attached with favorable demographic trend such as geriatric population. Growing awareness regarding the advantages of early diagnostics is further likely to propel the growth of the market in this region.

LAMEA is expected to witness a steady growth during the forecasted period due to the lack of knowledge and poor infrastructure development.

Report Coverage

Market

Molecular Diagnostics Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

 Product, Technology, application, End-User, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis,

Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The molecular diagnostics market comprises of some of the major players such as

  • Abbott Molecular Cepheid
  • BioMerieux’s
  • Roche diagnostics
  • Danaher Corporation
  • Siemens Healthcare
  • Qiagen Gaithersburg
  • Johnson and Johnson
  • Agilent (Dako)
  • GenMark diagnostics
  • Analytik Jena and Alere Inc.

For instance, in November 2017, Hummingbird Diagnostics GmbH and Saarland University collaborated in early disease detection based on molecular markers.

Market Segmentation

Market By Product

  •  Instruments
  • Reagents
  • Software & Services

Market By Technology

  • Polymerase Chain Reactions (PCR)
  • Hybridization
  • DNA Sequencing
  • Microarray
  • Others

Market By Application

  •  Infectious Diseases
  • Oncology
  • Genetic Testing
  • Blood Screening
  • Others

Market By End-User

  • Hospital
  • Laboratories
  • Others

Market By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

 


Related Reports

Wound Dressing Market (By Product - Traditional, Advanced [Moist, Foam, Alginate, Film, Hydrocolloid, Hydrogel], Antimicrobial [Silver, Non - Silver], Interactive [ Biomaterials, Skin - Substitute]) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Moisture wound dressing is a clinical technique to create a moist around the wound in order to speed up the healing process and reduce scabs and scarring for beautiful skin. Moisture wound dressing promotes the growth and migration of new cells and also maintains the proteins that are essential for wound closure. The report provides analysis of global moisture wound

Infection Surveillance Solutions Market (By Product and Services - Software [ On-premise, Web-based], Services; By Infection Type - Surgical Site Infections (SSI), Blood Stream Infections (BSI), Urinary Tract Infections (UTI), Others; By End-use - Long Term Care Facilities, Hospitals, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare associated Infections (HAIs), or nosocomial contaminations, are the measure of the patient prosperity and health concerns coming about because of poor cleanliness, diminished patient immunity, carelessness and extra medicinal services uses. Infection surveillance is designed to constantly monito

Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction Hematology is a part of drug, which manages the study of blood, blood illnesses and blood-forming organs. Hematology incorporates issues related with white platelets, red platelets, bone marrow, lymph, and platelets. It additionally influences the fluid part of blood known as plasma. Hematology incorporates different IVD advancements, such as blood analysis, stream

Healthcare Contract Research Organization (CRO) Market (By Product - Drug Discovery, Pre-Clinical, Clinical; By Service - Project Management/Clinical Supply Management, Data Management, Regulatory/Medical Affairs, Medical Writing, Clinical Monitoring, Quality Management/ Assurance, Bio-statistics, Investigator Payments, Laboratory, Patient and site Recruitment, Technology, Others) Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Healthcare contract research organization (CRO) provides support and services as biologic assay development, clinical research, commercialization, preclinical research, clinical trials management and biopharmaceutical development to biotechnology, pharmaceutical and medical device industries. Healthcare co

Antibiotic Resistance Market (By Disease - cUTI, cIAI, BSI, CDI, ABSSSI, HABP/VABP, CABP; By Pathogen - Acinetobacter Baumannii, Pseudomonas Aeruginosa, Staphylococcus Aureus, E. coli/K. Pneumoniae, Streptococcus Pneumoniae, Clostridium difficile, Enterococcus faecium, Haemophilus Influenzae; By Drug Class - Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction    Antibiotic are medicines that are used to prevent various bacterial infections and antibiotic resistance is the inability of a microorganism to withstand the effects of an antibiotic. It is a specific type of drug resistance. These bacteria may infect humans and animals body, and the infections they cause

Sterility Indicators Market (By Type - Chemical Indicators, Biological Indicators; By Technique - Heat Sterilization, Low Temperature Sterilization, Filtration, Sterilization, Radiation Sterilization, Liquid Sterilization; By End-user - Hospitals, Pharmaceutical Companies, Medical device Companies, Clinical, laboratories/Research Centers, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Introduction The global sterility indicators market was valued at USD 547.5 million in 2017 in terms of revenue. It is expected to grow at a CAGR of 10.8% during the forecast period. Stringent regulations regarding healthcare products and greater emphasis on sterility parameters and methods for the prevention of Hospital Acquired Infections are anticipated to dr

Cart Summary